Back to the main directory
EarningsReview / Equity
- Malaysia Airports Holding (MAHB MK) by HSBC
- Frontline (Hold, TP: NOK72.00) - Minor estimate changes pre-Q2 by DnB Markets
- Kahoot (Buy, TP: NOK85.00) - Time to enter by DnB Markets
- Humana (Buy, TP: SEK85.00) - Continued solid execution by DnB Markets
- B2Holding Minor model adjustments by DnB Markets
- Bavarian Nordic - Full steam ahead as funding clears by Danske Bank Equity Research
- WOOD Daily: WPL PW, TEN PW, PGN PW, CPS PW, CCC PW/ALE PW, EUR PW/DNP PW, TLV RO, Previews by Wood and Company
- Apontis Pharma - Solid results following a successful IPO by Edison Investment Research
- Reinventing itself and still expanding margins by BNP Paribas Exane
- Lundbergs (Sell, TP: SEK530.00) - Hard to justify the premium to NAV by DnB Markets
- Kap Industrial Holdings (KAP SJ) by HSBC
- Nimbus Group - Buy/SEK 88 (85): Calm seas for a while longer by Nordea
- Investment Daily 25/08/2021 by BNP Paribas Exane
- Volue - Hold: SaaS journey remains well on track in Q2 by Nordea
- Hemnet Group - Hold: An exceptional quarter but an exceptional valuation by Nordea
- Investment Daily 23/08/2021 by BNP Paribas Exane
- Volting Ambitions by BNP Paribas Exane
- WOOD Daily: Polish banks, HU macro, WINE RO, EUR PW, GTC PW, TEN PW, WPL PW, Previews by Wood and Company
- H1 operating results ahead of forecasts by BNP Paribas Exane
- Kunlun Energy (135 HK) by HSBC
- Arena Hospitality Group - Eastward Ho! by Edison Investment Research
- Huazhu Group Limited (HTHT US) by HSBC
- PA Good Doctor (1833 HK) by HSBC
- Elekta - The case was never about H1 2021/22 by Danske Bank Equity Research
- Fosun International Ltd (656 HK) by HSBC
- Evolution (Buy, TP: SEK1800.00) - Late-summer player improvement by DnB Markets
- Maersk Drilling (Buy, TP: DKK285.00) - Beaten up a little too much by DnB Markets
- Wilh. Wilhelmsen Holding (Buy, TP: NOK263.00) - Set for recovery and growth by DnB Markets
- Royal Unibrew (Hold, TP: DKK890.00) - Higher guidance, but 2022 costs up by DnB Markets
- Hufvudstaden - Sell/SEK 130 (120): Weakest growth outlook in our coverage by Nordea
- Improving but still lagging by BNP Paribas Exane
- 北方华创（002371 CH） by HSBC
- Riber - Pandemic causes temporary revenue slowdown by Edison Investment Research
- Elopak (Buy, TP: NOK32.00) - Q2 in line, but soft outlook for H2 by DnB Markets
- Strong outlook remains, but upside potential looks more limited by DnB Markets
- Benchmark Holdings Plc (BMK LN) by HSBC
- Royal Unibrew - Difficult times to be busy by Danske Bank Equity Research
- Mekonomen - Buy/SEK 190 (170): Good momentum continues by Nordea
- HusCompagniet - Buy/DKK 220 (200): Solid foundation for a very strong 2022 by Nordea
- H121 postview (+15 questions for management) by BNP Paribas Exane
- EQS Group - Whistleblowing deadline fast approaching by Edison Investment Research
- Stern Groep - A strong H1, more emphasis on used/rental by Edison Investment Research
- Razer Inc (1337 HK) by HSBC
- Panoro Energy - Starting to flourish by Danske Bank Equity Research
- China Resources Beer (291 HK) by HSBC
- 平安银行（000001 CH） by HSBC
- VivoPower International - Strategic progress masked by COVID shutdowns by Edison Investment Research
- Doctor Care Anywhere Group - Growing momentum following record month by Edison Investment Research
- JD Health International (6618 HK) by HSBC
- It''s got the right tools, but needs to deliver on cash by BNP Paribas Exane